Crucell Sweden AB cooperates with Remedium, the Northern and Central Eastern European CRO.

Crucell Sweden AB and Remedium have decided to collaborate in the field of clinical trials, covering both production and distribution of vaccines as well as managing the clinical trials.

Remedium is a privately owned Contract Research Organization with 110 employees offering clinical trial services for Phase I-IV Vaccine trials to the pharmaceutical industry and biotech companies both in Europe and the US. Remedium coverage offers the ideal situation for running these vaccine trials which involve high patient recruitment while maintaining low cost. Remedium has offices in Finland, Sweden, Denmark, Norway, Estonia, Lithuania and Poland as well as staff coverage in Romania and has a distinguished track record in vaccine trials.